DUBLIN–(BUSINESS WIRE)–The “Peripheral Nerve Stimulators (PNS) – Medical Devices Pipeline Product Landscape, 2021” report has been added to ResearchAndMarkets.com’s offering.
This report provides comprehensive information about the Peripheral Nerve Stimulators (PNS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A Peripheral nerve stimulation device is similar to the spinal cord stimulation (SCS ) device that is used to treat chronic pain disorders. A PNS is comprised of an electrical pacemaker that stimulates the peripheral nerve through the surgically-implanted electrodes.
Scope
- Extensive coverage of the Peripheral Nerve Stimulators (PNS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripheral Nerve Stimulators (PNS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripheral Nerve Stimulators (PNS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Key Topics Covered:
1 Tables & Figures
2 Introduction
2.1 Peripheral Nerve Stimulators (PNS) Overview
3 Products under Development
3.1 Pipeline Products by Stage of Development
3.2 Pipeline Products by Territory
3.3 Pipeline Products by Regulatory Path
3.4 Pipeline Products by Estimated Approval Date
3.5 Ongoing Clinical Trials
4 Peripheral Nerve Stimulators (PNS) – Pipeline Products under Development by Companies
4.1 Peripheral Nerve Stimulators (PNS) Companies – Pipeline Products by Stage of Development
4.2 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Stage of Development
5 Peripheral Nerve Stimulators (PNS) Companies and Product Overview
5.1 Actuated Medical Inc Company Overview
5.1.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Bioness Inc Company Overview
5.3 Cala Health Inc Company Overview
5.4 Cardionomic Inc Company Overview
5.5 Charco Neurotech Ltd Company Overview
5.6 Checkpoint Surgical Inc Company Overview
5.7 EMKinetics, Inc. Company Overview
5.8 Epineuron Technologies Inc Company Overview
5.9 Gondola Medical Technologies SA Company Overview
5.10 Noctrix Health Inc Company Overview
5.11 Remedee Labs SAS Company Overview
5.12 SPR Therapeutics LLC Company Overview
5.13 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.14 TheraNova LLC Company Overview
5.15 Washington University School of Medicine Company Overview
6 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/ialwbs
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900